Newsroom
March 1, 2022
Bioventus Receives 510(k) Clearance for StimRouter Pain Management Device
Industry Leading Peripheral Nerve Stimulator Upgraded to Improve Patient User Experience with Control of their Unique Chronic Pain Condition, Longer…
March 1, 2022
Bioventus Appoints Mark Singleton as Chief Financial Officer
DURHAM, NC – February 28, 2022 – Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing,…
January 11, 2022
Bioventus Announces Preliminary Fourth Quarter and Full-Year 2021 Revenue
DURHAM, NC – January 11, 2022 – Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing,…
December 28, 2021
Bioventus to Present at the 40th Annual J.P. Morgan Healthcare Conference
DURHAM, NC – December 28, 2021 – Bioventus Inc. (Nasdaq: BVS), a global leader in innovations for active healing, today announced that Ken Reali,…
December 21, 2021
Bioventus Appoints Michelle McMurry-Heath to Board of Directors
DURHAM, NC – December 21, 2021 – Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, has…
December 20, 2021
Bioventus Receives US FDA Clearance for BoneScalpel® Access™
DURHAM, NC – December 20, 2021 – Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing,…
November 18, 2021
Bioventus to Expand Operations and Manufacturing in Memphis
MEMPHIS, TN – November 18, 2021 – Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, has…
November 15, 2021
Bioventus Announces Chief Financial Officer Transition Plan
DURHAM, NC – November 15, 2021 – Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or “the Company”), a global leader in innovations…
November 9, 2021
Bioventus Reports Third Quarter Results; Updates Full-Year 2021 Financial Guidance
DURHAM, NC – November 9, 2021 – Bioventus Inc. (Nasdaq: BVS) ("Bioventus" or "the Company"), a global leader in innovations for active healing, today…
November 1, 2021
Sharon Klugewicz Joins Bioventus as Senior Vice President, Quality and Regulatory Affairs
DURHAM, NC – November 1, 2021 – Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, has…
